Estherline Thoby | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Estherline J. Thoby
Rutgers Robert Wood Johnson Medical School, United States

Estherline Thoby
Affiliation Rutgers Robert Wood Johnson Medical School
Country United States
Scopus ID 57201254799
Documents 4
Citations 26
h-index 2
Subject area Medicine and Health Sciences
Event Global Innovation Technologist Awards

The Innovative Research Award profile presents Estherline Thoby’s documented scholarly activity in medicine and health sciences, with particular attention to pediatric practice and neonatal hyperbilirubinemia. Her listed publication, “Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines,” addresses clinical practice in the context of updated guidance for neonatal jaundice. The profile summarizes the supplied bibliometric information and identifies the research themes relevant to academic recognition. The available information does not establish an award decision or independent assessment outcome.

Abstract

Estherline J. Thoby is associated with research in pediatric medicine and neonatal hyperbilirubinemia. Her listed 2026 publication examines pediatricians’ practice patterns concerning the revised 2022 neonatal hyperbilirubinemia guidelines. This topic is relevant to understanding how clinical recommendations are interpreted and applied in pediatric settings. The supplied Scopus profile reports four documents, 26 citations and an h-index of 2. These figures provide a limited bibliometric snapshot rather than a complete evaluation of clinical relevance, methodological quality or research contribution. [1]

Keywords

Estherline Thoby; neonatal hyperbilirubinemia; pediatric practice; clinical guidelines; neonatal jaundice; evidence-based medicine; pediatricians; medicine and health sciences; research impact.

Introduction

Neonatal hyperbilirubinemia is a common clinical concern involving elevated bilirubin levels in newborns. Clinical guidelines support decisions about risk assessment, monitoring and treatment. Examining pediatricians’ practice patterns can help describe the relationship between published recommendations and real-world clinical approaches. The 2022 revised guidance provides the context for the publication attributed to Thoby and co-authors. The available citation information identifies a relevant research topic, but detailed findings should be drawn from the full article rather than inferred from its title. [2]

Research Profile

The supplied institutional affiliation is Rutgers Robert Wood Johnson Medical School in the United States. The profile identifies medicine and health sciences as the subject area. The reported bibliometric indicators are four documents, 26 citations and an h-index of 2. These metrics describe indexed scholarly output and citation activity as supplied; they may change as databases are updated. The information provided does not independently verify employment dates, authorship contributions or the completeness of the publication record.

Research Contributions

The identified research topic concerns the implementation of revised neonatal hyperbilirubinemia guidance in pediatric practice. Research on practice patterns can help characterize clinicians’ familiarity with recommendations and identify areas for further education or investigation. However, specific conclusions about adherence, treatment choices or patient outcomes cannot be established from the citation metadata alone. Assessment of these contributions requires the full publication, including its methods, results and limitations.

Publications

The supplied publication record is:

  • Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines. Authors listed: E. J. Thoby, A. A. Lariviere, K. A. Briski and A. Petrova. Pediatric Reports, 2026. The supplied record reports zero citations for this individual article at the time of the provided snapshot.

A DOI and direct full-text URL were not supplied and are therefore not asserted here. The publication title and author details should be checked against the journal’s official record before formal bibliographic reuse.

Research Impact

The supplied Scopus figures indicate a modest indexed publication record with measurable citation activity. Citation counts and h-index can support comparisons when interpreted alongside career stage, specialty, authorship role and publication context. They do not independently measure clinical influence, originality or patient benefit. Because the identified 2026 article is reported with zero citations, its potential influence should be assessed over time and through substantive review of its findings.

Award Suitability

The Innovative Research Award profile for the Global Innovation Technologist Awards provides a framework for presenting the researcher’s subject area, publication activity and research interests. Relevant considerations for a formal award evaluation include:

  • Relevance and originality of the research question.
  • Methodological quality and transparency of reported findings.
  • Potential contribution to pediatric practice and evidence-based care.
  • Verified publication records and independently documented research outcomes.

These considerations are evaluation criteria, not confirmation that an award has been granted. A final determination requires the event’s official assessment process and supporting evidence.

Conclusion

Estherline Thoby’s listed work addresses a clinically relevant topic in neonatal and pediatric medicine. The available profile provides basic bibliometric information and a 2026 publication reference, while leaving the article’s detailed findings and broader clinical implications to be verified from primary sources. This page serves as a neutral academic recognition profile, not an independent validation of research quality or an announcement of award selection.

References

  1. Elsevier. (n.d.). Scopus author details: Author ID 57201254799. Scopus. Bibliometric figures reproduced from the information supplied for this profile.
    https://www.scopus.com/authid/detail.uri?authorId=57201254799
  2. Thoby, E. J., Lariviere, A. A., Briski, K. A., & Petrova, A. (2026). Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines. Pediatric Reports. Publication details are transcribed from the supplied citation; volume, issue, page range and DOI were not provided.
  3. Kemper, A. R., Newman, T. B., Slaughter, J. L., et al. (2022). Clinical practice guideline revision: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 150(3), e2022058859.
    https://doi.org/10.1542/peds.2022-058859
  4. World Health Organization. (n.d.). Newborn health. World Health Organization. General reference for newborn health context.
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mehmet Kızılkaya | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Mehmet Kızılkaya
Trabzon Kanuni Training and Research Hospital, Turkey

Mehmet Kızılkaya
Affiliation Trabzon Kanuni Training and Research Hospital
Country Turkey
Google Scholar ID LoT5L1kAAAAJ
Documents 1
Citations 1
h-index 1
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

Mehmet Kızılkaya is a researcher affiliated with Trabzon Kanuni Training and Research Hospital in Turkey, working within the broad field of Medicine and Health Sciences. The available publication record identifies a 2026 research contribution concerning prognostic indicators in older patients with prostate cancer undergoing definitive radiotherapy. The documented work examines myopenia, myosteatosis, and frailty as clinically relevant characteristics in this patient population. [1]

Abstract

This academic recognition profile presents the available research record associated with Mehmet Kızılkaya. The documented publication addresses the prognostic significance of myopenia, myosteatosis, and frailty among older patients with prostate cancer receiving definitive radiotherapy. These variables represent aspects of muscle quantity, muscle quality, and overall vulnerability that may contribute to the clinical characterization of older oncology patients. The publication appeared in Cancer Control in 2026 and lists Kızılkaya among its authors. [1]

Keywords

  • Prostate cancer
  • Radiotherapy
  • Myopenia
  • Frailty
  • Geriatric oncology

Introduction

Age-associated changes in muscle mass, muscle composition, and functional reserve are increasingly considered in the assessment of older adults with cancer. In prostate cancer, definitive radiotherapy is an established treatment approach, while patient-level characteristics can influence prognosis and treatment planning. The reported study focuses specifically on myopenia, myosteatosis, and frailty, providing a clinical research perspective on these factors in older patients receiving radiotherapy. [1]

Research Profile

The available bibliographic information records one research document and one citation, with an h-index of 1 in the supplied profile data. The documented publication is situated within Medicine and Health Sciences and concerns an interdisciplinary clinical question connecting oncology, radiotherapy, geriatric assessment, and body-composition-related prognostic factors. Because only a limited set of bibliometric information is available, broader measures of research productivity and longitudinal impact should be interpreted cautiously.

Research Contributions

Kızılkaya’s documented contribution is part of a multi-author investigation of prognostic characteristics in older patients with prostate cancer. The study’s focus on myopenia, myosteatosis, and frailty contributes to a research framework in which conventional cancer outcomes can be considered alongside patient-specific physical characteristics. The work also illustrates collaboration across clinical disciplines involved in cancer management and radiotherapy. [1]

Publications

Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy — RA Aksoy, T Koca, DA Çetmi, M Kızılkaya, and AF Korcum. Published in Cancer Control, volume 33, in 2026. The available record reports article identifier 10732748261446040 and one citation. [1]

Research Impact

The available citation record documents an early bibliometric impact for the reported publication. With one document and one citation in the supplied data, quantitative indicators remain limited and should not be interpreted as a comprehensive measure of scholarly influence. The clinical relevance of the research can instead be understood through its focus on prognostic assessment in an older prostate-cancer population and its integration of muscle-related and frailty-related characteristics. [1]

Award Suitability

For the Innovative Research Award associated with the Global Innovation Technologist Awards, the documented research provides identifiable evidence of participation in contemporary clinical research involving prostate cancer, definitive radiotherapy, and prognostic characteristics of older patients. Relevant considerations include the specificity of the research question, its multidisciplinary clinical context, and the publication record available for verification. A complete award assessment would require the relevant official profile identifiers and any additional documented research outputs supplied for evaluation.

Conclusion

The available record identifies Mehmet Kızılkaya as a contributor to research examining myopenia, myosteatosis, and frailty in older patients with prostate cancer undergoing definitive radiotherapy. The publication establishes a clear connection with Medicine and Health Sciences and provides a documented basis for recognizing research activity in clinical oncology. Additional publications, identifiers, citations, and longitudinal metrics would allow a more comprehensive assessment of the research profile.

References

  1. Aksoy, R. A., Koca, T., Çetmi, D. A., Kızılkaya, M., & Korcum, A. F. (2026). Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy.
    https://journals.sagepub.com/doi/full/10.1177/10732748261446040
  2. Cancer Control. (2026). Bibliographic record for the reported prostate cancer radiotherapy research article.
  3. Google Scholar. (2026). Citation record associated with the reported publication.
  4. Global Innovation Technologist Awards. (n.d.). Official awards website.
    innovationtechnologist.com
  5. SAGE Journals. (n.d.). Cancer Control: Journal information and publication platform.

JongHyun Kim | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

JongHyun Kim
Korea Institute of Industrial Technology, South Korea

JongHyun Kim
Affiliation Korea Institute of Industrial Technology
Country South Korea
Documents 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-9498-4746

JongHyun Kim is a researcher affiliated with the Korea Institute of Industrial Technology whose recent scholarly record includes work connecting digital measurement, biomedical engineering, and emerging technologies for healthcare applications. The documented publications indicate an interdisciplinary research orientation within Medicine and Health Sciences, with particular relevance to technology-enabled measurement and bio-electronic systems.

Abstract

This article presents a scholarly profile of JongHyun Kim in the context of the Innovative Research Award. His documented research includes a 2026 study addressing accuracy verification and correction in a depth-camera-based digital measurement system for pelvic balance assessment during the Trendelenburg test, as well as a review concerning laser-based optical wireless power transfer for bio-electronic medicine. These publications demonstrate engagement with digital measurement and emerging biomedical technologies. [1] [2]

Keywords

Digital measurement; depth cameras; pelvic balance assessment; Trendelenburg test; bio-electronic medicine; optical wireless power transfer; laser technology; healthcare innovation.

Introduction

Contemporary healthcare research increasingly incorporates computational measurement systems and energy technologies designed to support clinical and biomedical applications. Kim’s recent publications fall within this broader technological context. The depth-camera study focuses on measurement accuracy and correction, while the bio-electronic medicine review examines the development of laser-based optical wireless power transfer. [1] [2]

Research Profile

The available record identifies two journal articles published in 2026. The first, published in Electronics on September 4, 2026, addresses accuracy verification and correction for digital pelvic balance measurement. The second, published in Medical Lasers on March 30, 2026, provides a comprehensive review of laser-based optical wireless power transfer in bio-electronic medicine. [1] [2]

Research Contributions

  • Development-oriented research on digital measurement accuracy for pelvic balance assessment.
  • Investigation of correction approaches for depth-camera-based measurement systems.
  • Scholarly synthesis of laser-based optical wireless power transfer for bio-electronic medicine.

Publications

“Accuracy Verification and Correction of a Depth-Camera-Based Digital Measurement System for Pelvic Balance Assessment in the Trendelenburg Test.” Electronics, published September 4, 2026. [1]

“Towards energy autonomy in bio-electronic medicine: a comprehensive review of laser-based optical wireless power transfer evolution.” Medical Lasers, published March 30, 2026. [2]

Research Impact

The documented work has relevance to the intersection of measurement science, digital healthcare, biomedical engineering, and energy delivery for electronic medical systems. The available publication evidence supports a research profile characterized by applied technological investigation and interdisciplinary biomedical relevance. Citation and h-index values were not supplied and are therefore not estimated in this profile.

Award Suitability

Based on the supplied publication record, Kim’s research is relevant to an Innovative Research Award because the documented studies address practical technological challenges in healthcare. The combination of digital measurement validation and emerging optical power-transfer research provides evidence of engagement with innovation-oriented biomedical technology. [1] [2]

Conclusion

JongHyun Kim’s available 2026 publication record demonstrates research activity spanning digital clinical measurement and bio-electronic technology. The two documented journal articles provide a focused basis for recognizing contributions to technology-enabled healthcare research while leaving bibliometric indicators such as citations and h-index for verification through authoritative researcher databases.

References

  1. Kim, JongHyun, et al. (2026). Accuracy Verification and Correction of a Depth-Camera-Based Digital Measurement System for Pelvic Balance Assessment in the Trendelenburg Test. Electronics. DOI: 10.3390/electronics15173988.
    https://doi.org/10.3390/electronics15173988
  2. Kim, JongHyun, et al. (2026). Towards energy autonomy in bio-electronic medicine: a comprehensive review of laser-based optical wireless power transfer evolution. Medical Lasers. DOI: 10.25289/ML.26.003.
    https://doi.org/10.25289/ML.26.003
  3. ORCID. (n.d.). ORCID record for JongHyun Kim.
    https://orcid.org/0000-0002-9498-4746
  4. Elsevier. (n.d.). ORCID: Abstract and citation database.
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com
  6. Multidisciplinary biomedical technology literature indexed through scholarly journal publication records, including the cited Electronics and Medical Lasers articles.

Ignacio Gondolesi | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Ignacio Gondolesi
Mount Sinai Health System, United States

Ignacio Gondolesi
Affiliation Mount Sinai Health System
Country United States
Scopus ID 57757842400
Documents 5
Citations 1
h-index 1
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

Ignacio Gondolesi is a medical researcher affiliated with Mount Sinai Health System whose documented scholarly work addresses clinically relevant questions across endocrinology, infectious disease, cardiovascular health, transplantation, and healthcare access. His publication record includes collaborative research in peer-reviewed medical journals and reflects engagement with both individual clinical cases and broader observational or systematic evidence. [1]

Abstract

This academic recognition profile summarizes the documented research activities of Ignacio Gondolesi in Medicine and Health Sciences. The available record comprises five scholarly documents and one recorded citation, with research spanning rare metabolic disorders, infectious disease, cardiovascular risk, rural healthcare, and pediatric transplantation. His work demonstrates participation in multidisciplinary clinical research and case-based evidence generation. [1]

Keywords

Medicine and Health Sciences; clinical research; endocrinology; infectious disease; cardiovascular medicine; transplantation; healthcare access; systematic review; pediatric medicine.

Introduction

Clinical research contributes to evidence-based medicine by documenting patient presentations, identifying risk factors, evaluating healthcare conditions, and examining outcomes in specialized populations. Gondolesi’s listed publications demonstrate involvement in several of these research approaches, including a systematic review, case report, observational study, and pediatric transplant case series. [2]

Research Profile

The documented profile contains five research documents, one citation, and an h-index of 1. These bibliometric indicators represent the currently supplied Scopus record and should be interpreted in relation to publication age, indexing coverage, collaboration patterns, and the developing nature of an individual research portfolio.

Research Contributions

  • Clinical investigation of hyperinsulinemic hypoglycemia in adolescents through case reporting and systematic evidence synthesis. [1]
  • Investigation of fulminant hepatic failure associated with secondary syphilis. [2]
  • Research concerning subclinical carotid atherosclerosis and cardiovascular risk among young adults. [3]
  • Contribution to research on healthcare access and cardiovascular risk factors in rural populations. [4]
  • Participation in pediatric transplantation research involving SARS-CoV-2-positive donors. [5]

Publications

The publication record includes articles in Clinical Diabetes and Endocrinology, Cureus, Archivos de Cardiología de México, and Pediatric Transplantation, together with an accepted observational study. Topics range from metabolic and infectious disease presentations to cardiovascular prevention and complex pediatric transplantation. [1] [5]

Research Impact

The current quantitative record indicates a developing scholarly impact profile. Although the supplied citation count is limited, several publications address clinically important problems and involve international or multidisciplinary collaboration. DOI-indexed publications provide persistent identifiers that facilitate scholarly discovery and verification.

Award Suitability

For consideration under the Best Researcher Award category of the Global Innovation Technologist Awards, the documented portfolio provides evidence of active participation in medical research across multiple clinical domains. Suitability should be assessed using the complete nomination dossier, publication quality, methodological contribution, peer-reviewed outputs, collaboration, and independently verifiable research impact rather than bibliometric indicators alone.

Conclusion

Ignacio Gondolesi’s documented research portfolio reflects multidisciplinary engagement with contemporary medical and health-science questions. The five listed documents provide evidence of contributions spanning clinical case analysis, systematic review, cardiovascular epidemiology, healthcare access, and transplantation medicine. Continued publication and citation development may further clarify the long-term impact of this emerging research profile.

References

  1. Castillo-López MG, Fernandez MF, Sforza N, et al. Hyperinsulinemic hypoglycemia in adolescents: case report and systematic review. Clinical Diabetes and Endocrinology. 2022;8(1):3. doi:10.1186/s40842-022-00138-x.
    https://doi.org/10.1186/s40842-022-00138-x
  2. Gondolesi I, Vigliano CA, Fraile A, Descalzi VI, Perez Illidge LC. Secondary Syphilis Presenting as Fulminant Hepatic Failure: A Case Report and Literature Review. Cureus. 2025;17(2):e78887. doi:10.7759/cureus.78887.
    https://doi.org/10.7759/cureus.78887
  3. Giunta G, Pérez MF, Aguiló MF, Gondolesi I, et al. Prevalence and risk factors associated to subclinical carotid atherosclerosis in young adults. Archivos de Cardiología de México. 2026. doi:10.24875/ACM.25000189.
    https://doi.org/10.24875/ACM.25000189
  4. Gondolesi I, Newton M, Larocca AL, et al. Cardiovascular risk factors and healthcare access in a rural background at Los Telares. An Observational–Correlational study. Revista Argentina de Medicina. Accepted for publication.
  5. Brownell M, Gupta P, Moris D, et al. Using SARS-CoV-2-Positive Donors Under 1 Year of Age: A Case Series of Successful Combined Liver-Pancreas and Isolated Liver Pediatric Transplantation. Pediatric Transplantation. 2025;29(7):e70196. doi:10.1111/petr.70196.
    https://doi.org/10.1111/petr.70196

Muhammad Saif Ur Rahman | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Muhammad Saif Ur Rahman
Shenzhen University

Muhammad Saif Ur Rahman
Affiliation Shenzhen University
Country Pakistan
Scopus ID 57271810600
Documents 7
Citations 200
h-index 7
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-7010-724X

Muhammad Saif Ur Rahman is a researcher affiliated with Shenzhen University whose documented scholarly profile is situated within Medicine and Health Sciences. His listed research record includes work involving biomaterials, nanovaccines, cancer-related mechanobiology, peripheral nerve repair, drug delivery, and molecular materials research. The Research Excellence Award profile presents these activities in the context of academic research recognition and international scientific contribution.

Abstract

The Research Excellence Award profile recognizes the scholarly work of Muhammad Saif Ur Rahman at Shenzhen University. His publication record encompasses biomedical nanotechnology, biomaterials, cancer-related matrix mechanics, immunological applications, peripheral nerve regeneration, and therapeutic delivery systems. Selected publications demonstrate engagement with interdisciplinary questions connecting material properties, biological responses, and healthcare applications. His indexed profile lists 7 documents, 200 citations, and an h-index of 7, providing measurable indicators of research visibility.

Keywords

Biomaterials; nanovaccines; cancer mechanobiology; drug delivery; nerve regeneration; bioactive glass; biomedical engineering; molecular health sciences.

Introduction

Contemporary medicine increasingly integrates materials science, nanotechnology, and biological engineering to address complex therapeutic challenges. Rahman’s listed publications reflect this interdisciplinary direction, including studies of pore size and cancer cell behavior, nanovaccine strategies, biomaterial-assisted nerve repair, and mesoporous systems for therapeutic delivery. [1] [2]

Research Profile

The documented profile comprises seven Scopus-indexed documents, 200 citations, and an h-index of 7. The subject classification supplied for the award profile is Medicine and Health Sciences, while the publication portfolio shows substantial overlap with biomedical materials and nanomedicine. These indicators provide a concise quantitative context for evaluating the researcher’s scholarly activity.

Research Contributions

  • Investigation of matrix pore size as a mechanophysical factor influencing cancer cell behavior. [1]
  • Review of nanovaccine approaches for durable immunity against infectious diseases. [2]
  • Assessment of physical stimulation and biomaterials for peripheral nerve injury repair. [3]
  • Development of strontium-containing mesoporous bioactive glass nanoparticles for drug delivery and apatite formation. [4]

Publications

Selected publications include “Matrix mechanophysical factor: pore size governs the cell behavior in cancer,” published in Advances in Physics: X; “Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases” in ACS Nano; “Physical Stimulation Combined with Biomaterials Promotes Peripheral Nerve Injury Repair” in Bioengineering; “Hydroxycarbonate apatite formation and 5-fluorouracil delivery by strontium containing mesoporous bioactive glass nanoparticles” in Ceramics International; and “Mechanisms Affecting Physical Aging and Swelling by Blending an Amphiphilic Component” in International Journal of Molecular Sciences. [5]

Research Impact

The supplied bibliometric indicators of 200 citations and an h-index of 7 indicate that the researcher’s publications have received measurable scholarly attention. The diversity of journals and subject intersections also illustrates a research profile spanning biomedical materials, immunology-oriented nanotechnology, regenerative medicine, and therapeutic delivery.

Award Suitability

The profile is suitable for consideration within a research excellence framework because it combines documented publication activity, citation indicators, and interdisciplinary contributions in Medicine and Health Sciences. The evidence presented supports an evaluation based on scholarly output and research relevance rather than unsupported claims of distinction.

Conclusion

Muhammad Saif Ur Rahman’s research profile reflects interdisciplinary activity at the intersection of medicine, biomaterials, nanotechnology, and regenerative applications. His documented publications and citation indicators provide a foundation for academic recognition through the Research Excellence Award associated with the Global Innovation Technologist Awards.

References

  1. “Matrix mechanophysical factor: pore size governs the cell behavior in cancer.” Advances in Physics: X, 2023.
    https://doi.org/10.1080/23746149.2022.2153624
  2. “Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases.” ACS Nano, 2023.
    https://doi.org/10.1021/acsnano.3c07741
  3. “Physical Stimulation Combined with Biomaterials Promotes Peripheral Nerve Injury Repair.” Bioengineering, 2022.
    https://doi.org/10.3390/bioengineering9070292
  4. “Hydroxycarbonate apatite formation and 5-fluorouracil delivery by strontium containing mesoporous bioactive glass nanoparticles.” Ceramics International, 2022.
    https://doi.org/10.1016/j.ceramint.2022.02.126
  5. “Mechanisms Affecting Physical Aging and Swelling by Blending an Amphiphilic Component.” International Journal of Molecular Sciences, 2022.
    https://doi.org/10.3390/ijms23042185
  6. Elsevier. (n.d.). Scopus author details: Muhammad Saif Ur Rahman, Author ID 57271810600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57271810600
  7. ORCID. (n.d.). Muhammad Saif Ur Rahman, ORCID 0000-0001-7010-724X. ORCID.
    https://orcid.org/0000-0001-7010-724X

Aleksandra Kułakowska | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Aleksandra Kułakowska
University of Opole

Aleksandra Kułakowska
Affiliation University of Opole
Country Poland
Documents 9
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-5466-7167

Aleksandra Kułakowska is a researcher affiliated with the University of Opole whose scholarly work contributes to contemporary discussions in medicine, public health, patient care, and clinical practice. Her publications explore diverse healthcare topics including nephrology, cardiology, dermatology, women’s health, infection prevention, and quality-of-life assessment. Through peer-reviewed academic articles, she has participated in the dissemination of evidence-based medical knowledge and interdisciplinary healthcare perspectives.[1]

Abstract

This article presents an overview of the academic profile and scholarly contributions of Aleksandra Kułakowska. Her published work addresses clinically relevant healthcare challenges, emphasizing patient well-being, disease management, preventive medicine, and evidence-based healthcare practices. The breadth of topics represented within her publication portfolio demonstrates engagement with multidisciplinary medical research and healthcare education.[2]

Keywords

Medicine, Health Sciences, Clinical Research, Patient Care, Public Health, Dialysis, Medical Education, Healthcare Quality.

Introduction

Healthcare research plays an important role in improving patient outcomes and informing clinical decision-making. Aleksandra Kułakowska’s academic contributions align with this objective by addressing issues related to chronic disease management, healthcare quality, and patient-centered care. Her work contributes to broader efforts aimed at enhancing understanding of medical conditions and treatment outcomes.[3]

Research Profile

The research interests of Aleksandra Kułakowska encompass several areas of medicine and health sciences. Her publications address dialysis and quality of life, mental health implications of chronic treatment, surgical site infection prevention, women’s health, cardiovascular disorders such as Brugada syndrome, and rare dermatological conditions including Schnitzler syndrome. These studies demonstrate interdisciplinary engagement with contemporary healthcare topics.[4]

Research Contributions

  • Evaluation of quality-of-life outcomes among dialysis patients.
  • Assessment of mental health considerations associated with chronic renal therapy.
  • Review of updated guidelines concerning surgical site infections.
  • Analysis of healthy lifestyle interventions for patients experiencing PMS symptoms.
  • Compilation of clinically relevant information regarding Brugada syndrome.

Publications

  • Schnitzler syndrome – a rare cause of chronic urticaria. Case report (2025).
  • What impact does dialysis have on the patient’s life and mental health? (2023).
  • Dialysotherapy effect on the quality of life for renal patients (2023).
  • Surgical site infections – an updated review of guidelines (2023).
  • Holistic care, physical activity and healthy lifestyle in PMS patients (2023).

Research Impact

The published studies contribute to healthcare education and clinical awareness by synthesizing current evidence and discussing practical implications for patient care. Topics such as chronic disease management, infection prevention, and rare disease recognition are relevant to clinicians, healthcare educators, and medical researchers. The diversity of subjects represented in her work reflects a commitment to supporting informed healthcare practice.[5]

Award Suitability

Aleksandra Kułakowska’s scholarly activities align with the objectives of the Global Innovation Technologist Awards by demonstrating engagement with healthcare innovation, medical knowledge dissemination, and interdisciplinary research. Her publication record highlights contributions to clinically relevant topics that support evidence-based practice and ongoing scientific dialogue within medicine and health sciences.[6]

Conclusion

Aleksandra Kułakowska has contributed to a range of healthcare-related subjects through peer-reviewed publications addressing patient outcomes, clinical management, and public health concerns. Her academic portfolio reflects sustained engagement with contemporary medical issues and supports the advancement of healthcare knowledge through scholarly communication.

References

  1. ORCID. (n.d.). Aleksandra Kułakowska ORCID record.
    https://orcid.org/0000-0001-5466-7167
  2. Oxford Medical Case Reports. (2025). Schnitzler syndrome – a rare cause of chronic urticaria. Case report.
    DOI: https://doi.org/10.1093/omcr/omaf118
  3. Journal of Education, Health and Sport. (2023). What impact does dialysis have on the patient’s life and mental health?
    DOI: https://doi.org/10.12775/JEHS.2023.39.01.001
  4. Journal of Education, Health and Sport. (2023). Dialysotherapy effect on the quality of life for renal patients.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.006
  5. Journal of Education, Health and Sport. (2023). Surgical site infections – an updated review of guidelines in the light of new scientific data.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.002
  6. Journal of Education, Health and Sport. (2023). Concise compilation of the most clinically relevant current knowledge on Brugada Syndrome.
    DOI: https://doi.org/10.12775/JEHS.2023.25.01.001

Dominic Richmond | Health Professions | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Dominic Richmond
University of Birmingham, United Kingdom
Dominic Richmond
Affiliation University of Birmingham
Country United Kingdom
Scopus ID 57189870953
Documents 2
Citations 32
h-index 2
Subject Area Health Professions
Event Global Innovation Technologist Awards
ORCID 0009-0001-9270-937X

Dominic Richmond is a United Kingdom-based physiotherapy researcher and advanced clinical practitioner associated with the University of Birmingham and Cambridge University Hospitals NHS Foundation Trust. His academic and clinical work focuses on musculoskeletal rehabilitation, anterior cruciate ligament (ACL) injury management, sports physiotherapy, and evidence-based rehabilitation practices. Richmond has contributed to clinical research addressing return-to-sport outcomes and musculoskeletal injury prevention within elite athletic and healthcare environments.[1] His profile reflects a combination of academic achievement, clinical leadership, and interdisciplinary healthcare research aligned with contemporary health professions scholarship.[2]

Abstract

This article presents an academic overview of Dominic Richmond, a physiotherapist and healthcare researcher whose work has contributed to sports medicine, musculoskeletal rehabilitation, and anterior cruciate ligament research. Richmond’s clinical and academic activities integrate evidence-based rehabilitation methods with applied healthcare delivery in hospital and elite sporting environments. His published work and conference contributions demonstrate continuing engagement with ACL rehabilitation pathways, return-to-sport assessment methodologies, and injury risk mitigation strategies.[3] The profile also highlights his participation in healthcare leadership, interdisciplinary clinical practice, and research-oriented physiotherapy education.[4]

Keywords

Health Professions, Physiotherapy, ACL Rehabilitation, Sports Medicine, Musculoskeletal Research, Evidence-Based Practice, Clinical Rehabilitation, Knee Injury Research, Return-to-Sport Testing, Advanced Physiotherapy Practice

Introduction

Contemporary healthcare systems increasingly emphasize interdisciplinary rehabilitation, injury prevention, and evidence-informed physiotherapy interventions. Within this context, clinicians engaged in both practical and academic healthcare activities contribute significantly to the development of patient-centered rehabilitation frameworks. Dominic Richmond’s professional profile illustrates the integration of advanced physiotherapy practice with sports medicine research and musculoskeletal healthcare delivery.[5]

Richmond has worked across clinical, academic, and elite sports environments, including orthopaedic clinics, rehabilitation programs, and research-focused healthcare initiatives. His involvement with Cambridge University Hospitals NHS Foundation Trust and postgraduate studies at the University of Birmingham reflects continued engagement with advanced clinical reasoning, healthcare education, and translational rehabilitation research.[2]

Research Profile

Dominic Richmond’s research profile centers on physiotherapy, sports rehabilitation, and musculoskeletal injury management. His Scopus author profile records publications and citations related to ACL rehabilitation and return-to-sport methodologies.[1] His research interests include knee rehabilitation, strength and conditioning, injury prevention, and evidence-based physiotherapy interventions.

In addition to peer-reviewed publications, Richmond has participated in scientific conferences including the European College of Sport Science and UK Strength and Conditioning Association meetings. These activities demonstrate engagement with international scientific communication and collaborative research dissemination.[6]

  • Advanced Practice Physiotherapist specializing in knee rehabilitation and ACL pathways
  • Research involvement in sports medicine and return-to-sport evaluation
  • Participation in NIHR Health and Care Professional Internship Programme
  • Contributor to musculoskeletal physiotherapy education and clinical supervision

Research Contributions

Richmond has contributed to research examining injury rehabilitation strategies and musculoskeletal performance outcomes. His published and presented work includes investigations into ACL rehabilitation pathways and muscle-tendon mechanics associated with eccentric training interventions.[7]

His research collaborations have explored risk factors associated with sports-related injuries and return-to-sport testing after ACL reconstruction. These studies contribute to ongoing discussions concerning rehabilitation quality, athlete recovery, and evidence-based physiotherapy practice.[8]

  • Research on ACL injury priorities among at-risk female populations
  • Systematic review and meta-analysis related to return-to-sport testing
  • Conference presentations involving muscle-tendon mechanics and eccentric training
  • Clinical audit and healthcare improvement initiatives in musculoskeletal services

Publications

  1. Richmond, D., White, C., & Gomulko, T. Pass Rates of Return to Sport Test Batteries Following Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. Sports, 2026.
  2. Kay, A.D., Richmond, D., Talbot, C., Mina, M., Baross, A.W., & Blazevich, A.J. Stretching of Active Muscle Elicits Chronic Changes in Multiple Strain Risk Factors. Medicine & Science in Sports & Exercise, 2016.
  3. Research priorities for ACL injuries in at-risk groups – The female population. Published in Knee, 2025.[1]

Research Impact

Richmond’s academic output demonstrates measurable engagement within sports medicine and physiotherapy literature. According to Scopus metrics, his publications have received scholarly citations that reflect emerging influence within musculoskeletal rehabilitation research.[1] His work addressing ACL rehabilitation contributes to contemporary discussions concerning rehabilitation benchmarks, athlete recovery standards, and evidence-informed return-to-sport assessments.

Beyond publication metrics, Richmond’s research impact is reinforced by his participation in healthcare leadership programs, conference presentations, and integration of research findings into clinical rehabilitation pathways. Such contributions support broader healthcare objectives focused on patient outcomes, rehabilitation quality, and multidisciplinary collaboration.[4]

Award Suitability

Dominic Richmond’s professional and academic profile aligns with the objectives commonly associated with the Best Researcher Award within the Global Innovation Technologist Awards framework. His combined contributions to clinical physiotherapy, musculoskeletal rehabilitation research, healthcare education, and interdisciplinary sports medicine demonstrate engagement with both scientific inquiry and applied healthcare innovation.[9]

The integration of evidence-based rehabilitation methods into advanced clinical practice, alongside conference participation and peer-reviewed publications, reflects sustained commitment to healthcare advancement. His role in ACL rehabilitation leadership and musculoskeletal clinical services further supports recognition within professional health professions awards programs.[5]

Conclusion

Dominic Richmond represents an emerging contributor within physiotherapy and sports rehabilitation research. His academic publications, clinical leadership activities, and participation in healthcare-focused research initiatives collectively demonstrate ongoing engagement with musculoskeletal rehabilitation science and evidence-based healthcare practice. Through collaborative research, advanced clinical service delivery, and scholarly dissemination, Richmond contributes to the evolving landscape of health professions and rehabilitation medicine.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Dominic Richmond, Author ID 57189870953. Scopus.
    www.scopus.com/authid/detail.uri?authorId=57189870953
  2. University of Birmingham. (2025). Academic and professional profile associated with advanced physiotherapy studies and healthcare practice.
  3. ORCID. (2026). Dominic Richmond ORCID Profile.
    orcid.org/0009-0001-9270-937X
  4. Cambridge University Hospitals NHS Foundation Trust. (2026). Advanced Practice Physiotherapy and rehabilitation leadership activities.
  5. Richmond, D. (2026). Clinical rehabilitation and ACL management contributions in musculoskeletal healthcare.
  6. European College of Sport Science. (2013). Conference proceedings and research presentation abstracts involving muscle-tendon mechanics.
  7. Kay, A.D., Richmond, D., Talbot, C., Mina, M., Baross, A.W., & Blazevich, A.J. (2016). Stretching of Active Muscle Elicits Chronic Changes in Multiple Strain Risk Factors. Medicine & Science in Sports & Exercise.
  8. Richmond, D., White, C., & Gomulko, T. (2026). Pass Rates of Return to Sport Test Batteries Following Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. Sports.
    doi.org/10.3390/sports14050211
  9. Global Innovation Technologist Awards. (2026). International recognition framework for innovation and research excellence.
    innovationtechnologist.com

Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Dr. Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Levine Cancer Institute | United States

Dr. Catherine Frenkel is a surgeon-scientist specializing in head and neck oncology, surgical innovation, and clinical ethics. Her research integrates oncologic outcomes with ethical frameworks, particularly in areas such as robotic surgery, telesurgery, and decision-making in complex cancer care. She has contributed significantly to enhanced recovery after surgery (ERAS) protocols and multidisciplinary cancer treatment optimization. Her work also explores ethical challenges in transplantation and AI integration in surgical practice. Dr. Catherine Frenkel is actively involved in clinical research as a principal investigator, focusing on improving patient outcomes and healthcare delivery through evidence-based and ethically grounded innovations in surgical oncology.

                            Citation Metrics (Scopus)

300

250

200

150

100

50

0

 

Citations
197
Documents
20
h-index
7

Citations

Documents

h-index

View Scopus Profile  View Google Scholar Profile  View ORCID Profile

Featured Publications

Jiawen Wang | Medicine | Best Researcher Award

Published on by Innovation Technologist

Dr. Jiawen Wang | Medicine | Best Researcher Award

Surgeon at Longhua Hospital Shanghai University of Traditional Chinese Medicine | China

Jiawen Wang is a distinguished surgeon and deputy chief physician at a leading hospital specializing in Traditional Chinese Medicine, with a focused expertise in colorectal surgery and integrative medicine. She has made significant contributions to the clinical management of anorectal disorders and inflammatory bowel disease, combining traditional Chinese medicine approaches with minimally invasive surgical and endoscopic interventional techniques. As a principal investigator and key researcher in multiple competitive research projects, she has led studies that bridge traditional practices with modern medical science, investigating clinical outcomes and underlying biological mechanisms. Her scholarly output includes numerous peer-reviewed publications, contributions to books, and active participation as a reviewer for several academic journals. Her work has garnered recognition through multiple awards and patents, reflecting innovation and clinical impact. Collaborating with prominent institutions both nationally and internationally, she has advanced the application of integrative medicine in gastroenterology and pelvic floor medicine. She is also actively involved in professional societies, holding leadership and committee roles that influence clinical standards, research priorities, and training programs in colorectal and integrative medicine. Her contributions are characterized by the integration of traditional methodologies with evidence-based research, promoting high standards in both clinical practice and academic scholarship. She has achieved a total of 116 citations, with 112 citations since 2020, an h-index of 4 overall and since 2020, and an i10-index of 2 both total and since 2020, reflecting the recognition and influence of her work within the scientific and medical community. Her research and clinical practice demonstrate a unique capacity to combine innovation, rigorous scientific validation, and practical applicability, establishing her as a leading figure in the advancement of integrative approaches to colorectal and gastrointestinal medicine.

Profile: Orcid | Google Scholar

Featured Publications

1. Wang, J. W., Pan, Y. B., Cao, Y. Q., Wang, C., Jiang, W. D., Zhai, W. F., & Lu, J. G. (2020). Loganin alleviates LPS‐activated intestinal epithelial inflammation by regulating TLR4/NF‐κB and JAK/STAT3 signaling pathways. The Kaohsiung Journal of Medical Sciences, 36(4), 257–264.

2. Wang, J., Pan, Y., Cao, Y., Zhou, W., & Lu, J. (2019). Salidroside regulates the expressions of IL-6 and defensins in LPS-activated intestinal epithelial cells through NF-κB/MAPK and STAT3 pathways. Iranian Journal of Basic Medical Sciences, 22(1), 31.

3. Jiang, X., Chen, X., Dong, R., Wang, J., Pan, Y., & Cao, Y. (2023). Establishment of a mouse model of inflammatory bowel disease using dextran sulfate sodium. Advances in Clinical and Experimental Medicine, 32(5), 563–573.

4. Luo, Q., Wang, J., Ge, W., Li, Z., Mao, Y., Wang, C., & Zhang, L. (2024). Exploration of the potential causative genes for inflammatory bowel disease: Transcriptome-wide association analysis, Mendelian randomization analysis and Bayesian colocalisation. Heliyon, 10(7), [Article 7].

5. Liao, W., Luo, Q., Zhang, L., Wang, H., Ge, W., Wang, J., & Zuo, Z. (2024). Genetic overlap between inflammatory bowel disease and iridocyclitis: Insights from a genome-wide association study in a European population. BMC Genomic Data, 25(1), 92.